A detailed history of Loomis Sayles & CO L P transactions in Boston Scientific Corp stock. As of the latest transaction made, Loomis Sayles & CO L P holds 959 shares of BSX stock, worth $85,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
959
Previous 942 1.8%
Holding current value
$85,303
Previous $73,000 9.59%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $1,240 - $1,428
17 Added 1.8%
959 $80,000
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $1,279 - $1,476
19 Added 2.06%
942 $73,000
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $1,152 - $1,372
-20 Reduced 2.12%
923 $63,000
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $2,869 - $3,410
59 Added 6.67%
943 $55,000
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $4,968 - $5,413
99 Added 12.61%
884 $47,000
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $35,395 - $39,273
785 New
785 $39,000
Q2 2022

Aug 05, 2022

BUY
$35.24 - $47.1 $7,435 - $9,938
211 Added 66.77%
527 $20,000
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $6,625 - $7,306
-162 Reduced 33.89%
316 $14,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $2,284 - $2,692
-60 Reduced 11.15%
478 $20,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $82 - $91
2 Added 0.37%
538 $23,000
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $925 - $1,061
24 Added 4.69%
536 $23,000
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $6,242 - $7,021
-177 Reduced 25.69%
512 $20,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $1,889 - $2,392
-57 Reduced 7.64%
689 $25,000
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $25,692 - $31,503
746 New
746 $29,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.